Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Ávila-Moreno, Federico
825  Ergebnisse:
Personensuche X
?
1

Novel engineered recombinant ACE2 reduces SARS-CoV-2-induce..:

Ávila-Moreno, Federico
Molecular Therapy.  32 (2024)  2 - p. 282-283 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Targeted Demethylation of FOXP3-TSDR Enhances the Suppressi..:

Arroyo-Olarte, Rubén D. ; Flores-Castelán, Juan C. ; Armas-López, Leonel...
Inflammation.  , 2024
Link: https://doi.org/10.1007/..
 
?
3

Preclinical evidence in the assembly of mammalian SWI/SNF c..:

Trejo-Villegas, Octavio A. ; Heijink, Irene H. ; Ávila-Moreno, Federico
Molecular Therapy.  , 2024
Link: https://doi.org/10.1016/..
 
?
4

Driving CAR-T cells toward solid lung tumors:

Staal, Frank J.T. ; Avila-Moreno, Federico
Molecular Therapy: Oncology.  32 (2024)  1 - p. 200764 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Mexican Colorectal Cancer Research Consortium (MEX-CCRC): E..:

Andrade-Meza, Antonio ; Arias-Romero, Luis E. ; Armas-López, Leonel...
International Journal of Molecular Sciences.  24 (2023)  3 - p. 2115 , 2023
Link: https://doi.org/10.3390/..
 
?
6

A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression..:

Villamar-Cruz, Olga ; Loza-Mejía, Marco Antonio ; Vivar-Sierra, Alonso...
Molecular and Cellular Biology.  43 (2023)  12 - p. 631-649 , 2023
Link: https://doi.org/10.1080/..
 
?
7

Nanofitins and their applications in human health and lung ..:

Ávila-Moreno, Federico
Molecular Therapy.  31 (2023)  10 - p. 2813-2814 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Molecular transition of SARS-CoV-2 from critical patients d..:

De La Cruz-Montoya, Aldo Hugo ; Díaz Velásquez, Clara Estela ; Martínez-Gregorio, Héctor...
Frontiers in Cellular and Infection Microbiology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
9

Metformin Enhances TKI-Afatinib Cytotoxic Effect, Causing D..:

Barrios-Bernal, Pedro ; Hernandez-Pedro, Norma ; Orozco-Morales, Mario...
Pharmaceuticals.  15 (2022)  3 - p. 381 , 2022
Link: https://doi.org/10.3390/..
 
?
10

Variability in Susceptibility to Type I Interferon Response..:

Castro-Jiménez, Tannya Karen ; Gómez-Legorreta, Laura Cristina ; López-Campa, Laura Alejandra...
Frontiers in Cellular and Infection Microbiology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
11

Failure to EGFR-TKI-based therapy and tumoural progression ..:

Peralta-Arrieta, Irlanda ; Trejo-Villegas, Octavio A. ; Armas-López, Leonel...
European Journal of Cancer.  160 (2022)  - p. 189-205 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Will We Unlock the Benefit of Metformin for Patients with L..:

Barrios-Bernal, Pedro ; Zatarain-Barrón, Zyanya Lucia ; Hernández-Pedro, Norma...
Pharmaceuticals.  15 (2022)  7 - p. 786 , 2022
Link: https://doi.org/10.3390/..
 
?
13

Expression of Surfactant Protein D Distinguishes Severe Pan..:

Choreño-Parra, José Alberto ; Jiménez-Álvarez, Luis Armando ; Ramírez-Martínez, Gustavo...
The Journal of Infectious Diseases.  , 2021
Link: https://doi.org/10.1093/..
 
?
14

Corrigendum to "Macrophage Migration Inhibitory Factor Prom..:

Pacheco-Fernández, Thalia ; Juárez-Avelar, Imelda ; Illescas, Oscar...
Mediators of Inflammation.  2020 (2020)  - p. 1-2 , 2020
Link: https://doi.org/10.1155/..
 
?
15

CD47-SIRPαAxis as a Biomarker and Therapeutic Target in Can..:

Catalán, Rodrigo ; Orozco-Morales, Mario ; Hernández-Pedro, Norma Y....
Journal of Immunology Research.  2020 (2020)  - p. 1-8 , 2020
Link: https://doi.org/10.1155/..
 
1-15